LAMPERT MARK N - Insider Non-Derivative Transactions at CTI BIOPHARMA CORP (CTIC) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Jun 26, 2023, LAMPERT MARK N's relationship to CTI BIOPHARMA CORP (CTIC) is Director,TenPercentOwnerOther, and currently has 0 shares of Common Stock, par value $0.001.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTIC insiders.
Data Source: SEC.
LAMPERT MARK N - Insider Non-Derivative Transactions at CTIC
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Jun 27, 2023 | U -- (Common Stock, par value $0.001) | 3989130 | 9.1 | 0 |
| Jun 27, 2023 | U -- (Common Stock, par value $0.001) | 2595239 | 9.1 | 0 |
| Jun 27, 2023 | U -- (Common Stock, par value $0.001) | 43139 | 9.1 | 0 |
| Jun 27, 2023 | U -- (Common Stock, par value $0.001) | 1526147 | 9.1 | 0 |
| Jun 27, 2023 | U -- (Common Stock, par value $0.001) | 702505 | 9.1 | 0 |